Manufacturer of Controlled Substances; Notice of Registration, 25376 [2011-10865]

Download as PDF 25376 Federal Register / Vol. 76, No. 86 / Wesnesday, May 4, 2011 / Notices the following basic classes of controlled substances: DEPARTMENT OF JUSTICE Drug Enforcement Administration Drug Schedule Tetrahydrocannabinols (7370) ..... Ecgonine (9180) ........................... Morphine (9300) ........................... I II II The company plans to produce the listed controlled substances in bulk to be used in the manufacture of reagents and drug calibrator/controls which are DEA exempt products. Any other such applicant, and any person who is presently registered with DEA to manufacture such substances, may file comments or objections to the issuance of the proposed registration pursuant to 21 CFR 1301.33(a). Any such written comments or objections should be addressed, in quintuplicate, to the Drug Enforcement Administration, Office of Diversion Control, Federal Register Representative (ODL), 8701 Morrissette Drive, Springfield, Virginia 22152; and must be filed no later than July 5, 2011. Dated: April 25, 2011. Joseph T. Rannazzisi, Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration. [FR Doc. 2011–10861 Filed 5–3–11; 8:45 am] BILLING CODE 4410–09–P Manufacturer of Controlled Substances; Notice of Application Pursuant to § 1301.33(a), Title 21 of the Code of Federal Regulations (CFR), this is notice that on January 5, 2011, Johnson Matthey Pharma Services, 70 Flagship Drive, North Andover, Massachusetts 01845, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as a bulk manufacturer of the following basic classes of controlled substances: Drug Schedule Amphetamine (1100) .................... Methylphenidate (1724) ................ Hydrocodone (9193) ..................... II II II The company plans to utilize this facility to manufacture small quantities of the listed controlled substances in bulk and to conduct analytical testing in support of the company’s primary manufacturing facility in West Deptford, New Jersey. The controlled substances manufactured in bulk at this facility will be distributed to the company’s customers. Any other such applicant, and any person who is presently registered with DEA to manufacture such substances, may file comments or objections to the issuance of the proposed registration pursuant to 21 CFR 1301.33(a). Any such written comments or objections should be addressed, in quintuplicate, to the Drug Enforcement Administration, Office of Diversion Control, Federal Register Representative (ODL), 8701 Morrissette Drive, Springfield, Virginia 22152; and must be filed no later than July 5, 2011. Dated: April 28, 2011. Joseph T. Rannazzisi, Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration. [FR Doc. 2011–10913 Filed 5–3–11; 8:45 am] BILLING CODE 4410–09–P DEPARTMENT OF JUSTICE Drug Enforcement Administration Manufacturer of Controlled Substances; Notice of Registration By Notice dated January 26, 2011, and published in the Federal Register on February 3, 2011, 76 FR 6159, Johnson Matthey Inc., Pharmaceuticals Materials, 900 River Road, Conshohocken, Pennsylvania 19428, made application by letter to the Drug Enforcement Administration (DEA) to be registered as a bulk manufacturer of the following basic classes of controlled substances: Drug Schedule jlentini on DSKJ8SOYB1PROD with NOTICES Gamma Hydroxybutyric Acid (2010) ................................................................................................................................................... Amphetamine (1100) ........................................................................................................................................................................... Methylphenidate (1724) ....................................................................................................................................................................... Codeine (9050) .................................................................................................................................................................................... Oxycodone (9143) ............................................................................................................................................................................... Hydrocodone (9193) ............................................................................................................................................................................ Morphine (9300) .................................................................................................................................................................................. Thebaine (9333) .................................................................................................................................................................................. The company plans to manufacture the listed controlled substances in bulk for sale to its customers. The Thebaine (9333) will also be used to manufacture other controlled substances for sale in bulk to its customers. No comments or objections have been received. DEA has considered the factors in 21 U.S.C. 823(a) and determined that the registration of Johnson Matthey Inc. to manufacture the listed basic classes of controlled substances is consistent with the public interest at this time. DEA has investigated Johnson Matthey Inc. to ensure that the company’s registration is consistent with the public interest. The investigation has included inspection and testing of the company’s physical VerDate Mar<15>2010 17:45 May 03, 2011 Jkt 223001 security systems, verification of the company’s compliance with state and local laws, and a review of the company’s background and history. Therefore, pursuant to 21 U.S.C. 823(a), and in accordance with 21 CFR 1301.33, the above named company is granted registration as a bulk manufacturer of the basic classes of controlled substances listed. Dated: April 26, 2011. Joseph T. Rannazzisi, Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration. [FR Doc. 2011–10865 Filed 5–3–11; 8:45 am] BILLING CODE 4410–09–P PO 00000 Frm 00079 Fmt 4703 Sfmt 4703 I II II II II II II II DEPARTMENT OF LABOR Occupational Safety and Health Administration [Docket No. OSHA–2011–0059] Occupational Exposure to Hazardous Chemicals in Laboratories Standard; Extension of the Office of Management and Budget’s (OMB) Approval of Information Collection (Paperwork) Requirements Occupational Safety and Health Administration (OSHA), Labor. ACTION: Request for public comments. AGENCY: OSHA solicits public comments concerning its proposal to extend OMB approval of the SUMMARY: E:\FR\FM\04MYN1.SGM 04MYN1

Agencies

[Federal Register Volume 76, Number 86 (Wednesday, May 4, 2011)]
[Notices]
[Page 25376]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2011-10865]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances; Notice of Registration

    By Notice dated January 26, 2011, and published in the Federal 
Register on February 3, 2011, 76 FR 6159, Johnson Matthey Inc., 
Pharmaceuticals Materials, 900 River Road, Conshohocken, Pennsylvania 
19428, made application by letter to the Drug Enforcement 
Administration (DEA) to be registered as a bulk manufacturer of the 
following basic classes of controlled substances:

------------------------------------------------------------------------
                          Drug                               Schedule
------------------------------------------------------------------------
Gamma Hydroxybutyric Acid (2010)........................               I
Amphetamine (1100)......................................              II
Methylphenidate (1724)..................................              II
Codeine (9050)..........................................              II
Oxycodone (9143)........................................              II
Hydrocodone (9193)......................................              II
Morphine (9300).........................................              II
Thebaine (9333).........................................              II
------------------------------------------------------------------------

    The company plans to manufacture the listed controlled substances 
in bulk for sale to its customers. The Thebaine (9333) will also be 
used to manufacture other controlled substances for sale in bulk to its 
customers.
    No comments or objections have been received. DEA has considered 
the factors in 21 U.S.C. 823(a) and determined that the registration of 
Johnson Matthey Inc. to manufacture the listed basic classes of 
controlled substances is consistent with the public interest at this 
time. DEA has investigated Johnson Matthey Inc. to ensure that the 
company's registration is consistent with the public interest. The 
investigation has included inspection and testing of the company's 
physical security systems, verification of the company's compliance 
with state and local laws, and a review of the company's background and 
history. Therefore, pursuant to 21 U.S.C. 823(a), and in accordance 
with 21 CFR 1301.33, the above named company is granted registration as 
a bulk manufacturer of the basic classes of controlled substances 
listed.

    Dated: April 26, 2011.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 2011-10865 Filed 5-3-11; 8:45 am]
BILLING CODE 4410-09-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.